Parkinson’s Disease (PD) is one of the most common neurodegenerative diseases. Several molecular mechanisms are involved. The objective of conducting this study was to evaluate the expression of iNOS in mouse experimental model of PD. PD was induced through injecting mice with 10 doses of MPTP (25 mg/kg) and probenecid (250 mg/kg). Mice in control group were injected by saline (25 mg/kg). Immunohistochemical stains for iNOS in brain sections were carried out using indirect immunoperoxidase techniques. Study findings showed that there was a significant difference in the expression level iNOS in study groups (P<0.001), and experimental PD group had more expressed iNOS levels compared with control group. Taken together, the present study co...
Parkinson’s disease (PD) is characterized by the loss of dopaminergic neurons in the substantia nigr...
We have developed an animal model of degeneration of the nigrostriatal dopaminergic neurons, the neu...
The aetiology of Parkinson's disease (PD) is yet to be fully understood but it is becoming more and ...
Parkinson’s Disease (PD) is one of the most common neurodegenerative diseases. Several molecular mec...
Inflammatory processes described in Parkinson’s disease (PD) and its animal models appear to be impo...
The symptoms of Parkinson’s disease (PD) were first described nearly two centuries ago and its chara...
Upregulation of inflammatory response in the brain is associated with a number of neurodegenerative ...
Background: Reactive microglia have been associated with the histological changes that occur in Park...
Parkinson’s disease (PD) is one of the most prevalent neurodegenerative aging disorders characterize...
Increasing evidence suggests that neuroinflammation is an active process in Parkinson's disease (PD)...
Parkinson's disease (PD) is a neurodegenerative movement disorder characterized by the progressive l...
Purpose of Review: Neuroinflammation plays a significant role in Parkinson’s disease (PD) etiology a...
Reactive oxygen species (ROSs) are emerging as important players in the etiology of neurodegenerativ...
Increasing evidence suggests that neuroinflammation is an active process in Parkinson's disease (PD)...
Hirsch, Stéphane Hunot Parkinson’s disease is characterised by a slow and progressive degeneration o...
Parkinson’s disease (PD) is characterized by the loss of dopaminergic neurons in the substantia nigr...
We have developed an animal model of degeneration of the nigrostriatal dopaminergic neurons, the neu...
The aetiology of Parkinson's disease (PD) is yet to be fully understood but it is becoming more and ...
Parkinson’s Disease (PD) is one of the most common neurodegenerative diseases. Several molecular mec...
Inflammatory processes described in Parkinson’s disease (PD) and its animal models appear to be impo...
The symptoms of Parkinson’s disease (PD) were first described nearly two centuries ago and its chara...
Upregulation of inflammatory response in the brain is associated with a number of neurodegenerative ...
Background: Reactive microglia have been associated with the histological changes that occur in Park...
Parkinson’s disease (PD) is one of the most prevalent neurodegenerative aging disorders characterize...
Increasing evidence suggests that neuroinflammation is an active process in Parkinson's disease (PD)...
Parkinson's disease (PD) is a neurodegenerative movement disorder characterized by the progressive l...
Purpose of Review: Neuroinflammation plays a significant role in Parkinson’s disease (PD) etiology a...
Reactive oxygen species (ROSs) are emerging as important players in the etiology of neurodegenerativ...
Increasing evidence suggests that neuroinflammation is an active process in Parkinson's disease (PD)...
Hirsch, Stéphane Hunot Parkinson’s disease is characterised by a slow and progressive degeneration o...
Parkinson’s disease (PD) is characterized by the loss of dopaminergic neurons in the substantia nigr...
We have developed an animal model of degeneration of the nigrostriatal dopaminergic neurons, the neu...
The aetiology of Parkinson's disease (PD) is yet to be fully understood but it is becoming more and ...